Synonym
                                        ZD-8321; ZD 8321; ZD8321
                                     
                                    
                                        IUPAC/Chemical Name
                                        methyl ((S)-3-methyl-1-oxo-1-((S)-2-(((S)-1,1,1-trifluoro-4-methyl-2-oxopentan-3-yl)carbamoyl)pyrrolidin-1-yl)butan-2-yl)carbamate
                                     
                                    
                                    
                                    
                                        SMILES Code
                                        O=C(OC)N[C@@H](C(C)C)C(N1[C@H](C(N[C@@H](C(C)C)C(C(F)(F)F)=O)=O)CCC1)=O
                                     
                                    
                                    
                                        Purity
                                        >98% (or refer to the Certificate of Analysis)
                                     
                                    
                                        Shipping Condition
                                        Shipped under ambient temperature as non-hazardous chemical.  This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
                                     
                                    
                                        Storage Condition
                                        Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
                                     
                                    
                                        Solubility
                                        Soluble in DMSO
                                     
                                    
                                        Shelf Life
                                        >2 years if stored properly
                                     
                                    
                                        Drug Formulation
                                        This drug may be formulated in DMSO
                                     
                                    
                                        Stock Solution Storage
                                        0 - 4 C for short term (days to weeks), or -20 C for long term (months).
                                     
                                    
                                    
                                 
                             
                            
                                                        
                                                                
                                    Preparing Stock Solutions
                                    
                                        The following data is based on the
                                        product
                                        molecular weight
                                        423.43
                                        Batch specific molecular weights may vary
                                        from batch to batch
                                        due to the degree of hydration, which will
                                        affect the solvent
                                        volumes required to prepare stock solutions.
                                    
                                    
                                    
                                        
                                            
                                            
                                                | Concentration / Solvent Volume / Mass | 
                                                1 mg | 
                                                5 mg | 
                                                10 mg | 
                                            
                                            
                                            
                                            
                                                | 1 mM | 
                                                1.15 mL | 
                                                5.76 mL | 
                                                11.51 mL | 
                                            
                                            
                                                | 5 mM | 
                                                0.23 mL | 
                                                1.15 mL | 
                                                2.3 mL | 
                                            
                                            
                                                | 10 mM | 
                                                0.12 mL | 
                                                0.58 mL | 
                                                1.15 mL | 
                                            
                                            
                                                | 50 mM | 
                                                0.02 mL | 
                                                0.12 mL | 
                                                0.23 mL | 
                                            
                                            
                                        
                                     
                                 
                                                             
                            
                            
                                
                                    1: Kapui Z, Varga M, Urban-Szabo K, Mikus E, Szabo T, Szeredi J, Batori S,  Finance O, Aranyi P. Biochemical and pharmacological characterization of  2-(9-(2-piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-met  hylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a novel,  orally active elastase inhibitor. J Pharmacol Exp Ther. 2003 May;305(2):451-9.  PubMed PMID: 12606659.
2: Ohbayashi H. Neutrophil elastase inhibitors as treatment for COPD. Expert Opin  Investig Drugs. 2002 Jul;11(7):965-80. Review. PubMed PMID: 12084007.
3: Ohbayashi H. ZD-0892 AstraZeneca. Curr Opin Investig Drugs. 2000  Oct;1(2):227-9. PubMed PMID: 11249578.
4: Nozawa F, Hirota M, Okabe A, Shibata M, Iwamura T, Haga Y, Ogawa M. Elastase  activity enhances the adhesion of neutrophil and cancer cells to vascular  endothelial cells. J Surg Res. 2000 Dec;94(2):153-8. PubMed PMID: 11104655.
5: Veale CA, Bernstein PR, Bohnert CM, Brown FJ, Bryant C, Damewood JR Jr, Earley  R, Feeney SW, Edwards PD, Gomes B, Hulsizer JM, Kosmider BJ, Krell RD, Moore G,  Salcedo TW, Shaw A, Silberstein DS, Steelman GB, Stein M, Strimpler A, Thomas RM,  Vacek EP, Williams JC, Wolanin DJ, Woolson S. Orally active trifluoromethyl  ketone inhibitors of human leukocyte elastase. J Med Chem. 1997 Sep  26;40(20):3173-81. PubMed PMID: 9379436.